Literature DB >> 16723062

[Instrument for measuring psychological variables and adherence to treatment behavior in persons who are seropositive for HIV (VPAD-24)].

Julio Alfonso Piña López1, Andrés Ernesto Corrales Rascón, Katherine Mungaray Padilla, Manuel Alejandro Valencia Vidrio.   

Abstract

OBJECTIVE: To test the psychometric properties of an instrument for measuring psychological variables and adherence to treatment behaviors in persons with HIV infection or AIDS.
METHODS: A cross-sectional study was performed with 68 subjects who were seropositive for the human immunodeficiency virus (HIV) and who were being treated in a health facility in the city of Hermosillo (Sonora), Mexico, at the time the study was carried out. Five consecutive statistical testing procedures were applied for data analysis: the Student t test for comparison of means, for assessing the comprehensibility of the questions; an exploratory factorial analysis with varimax rotation for determining construct validity; Cronbach's alpha coefficient for determining reliability; Pearson's correlation coefficient (r) for assessing concurrent validity; and multiple linear regression for determining predictive value.
RESULTS: In 25 out of a total of 30 questions, the Student t test for comparison of means gave statistical significance values of P < or = 0.05, P < or = 0.005, P < or = 0.01, and P < or = 0.001. A four-factor structure was found with the factorial analysis with varimax rotation: (1) current adherence behavior and treatment; (2) underlying reasons for adherence or lack of adherence; (3) psychological well-being and social competencies; (4) past adherence behavior with values above 1 that, taken as a whole, explain 65.50% of the variance. An overall alpha coefficient of 0.852 was obtained with the test for reliability. The test for concurrent validity showed correlations between factors 1 and 2 (r = 0.615; P < or = 0.01), between factor 2 and factors 3 and 4 (r = -0.178; P < 0.05 and r = 0.265; P < 0,05, respectively), and between factor 3 and duration of infection in months (r = 0.265; P < 0.05). Finally, multiple linear regression showed that psychological factors 2 and 4, which together explain 48.6% of the variance, predicted current adherence behavior (adjusted determination coefficient [R2] = 0.486).
CONCLUSION: According to the results obtained, the instrument has optimal reliability as well as construct validity, concurrent validity, and predictive validity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16723062     DOI: 10.1590/s1020-49892006000400001

Source DB:  PubMed          Journal:  Rev Panam Salud Publica        ISSN: 1020-4989


  4 in total

1.  Psychological model of ART adherence behaviors in persons living with HIV/AIDS in Mexico: a structural equation analysis.

Authors:  José Luis Ybarra Sagarduy; Julio Alfonso Piña López; Mónica Teresa González Ramírez; Luis Enrique Fierros Dávila
Journal:  Rev Saude Publica       Date:  2017-09-04       Impact factor: 2.106

2.  Adherence to antiretroviral therapy for HIV/AIDS in Latin America and the Caribbean: Systematic review and meta-analysis.

Authors:  Jessica de Mattos Costa; Thiago Silva Torres; Lara Esteves Coelho; Paula Mendes Luz
Journal:  J Int AIDS Soc       Date:  2018-01       Impact factor: 5.396

3.  Psychological, interpersonal, and clinical factors predicting time spent on physical activity among Mexican patients with hypertension.

Authors:  José Luis Ybarra Sagarduy; Dacia Yurima Camacho Mata; José Moral de la Rubia; Julio Alfonso Piña López; José Luis Masud Yunes Zárraga
Journal:  Patient Prefer Adherence       Date:  2018-01-04       Impact factor: 2.711

4.  Validation study of a scale for assessing three personality functional dimensions among Venezuelan HIV-positive patients.

Authors:  José Moral de la Rubia; Gerymar Pastora Colombo Andrade; Arelys Carolina Torres Yépez; Víctor Manuel López Guerra; Julio Alfonso Piña López; José Luis Ybarra Sagarduy
Journal:  Psychol Res Behav Manag       Date:  2018-10-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.